Literature DB >> 3739751

Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-alpha-triglyceridemia.

L A Carlson, L Holmquist, P Nilsson-Ehle.   

Abstract

Hyper-alpha-triglyceridemia is a rare dyslipoproteinemia characterized by a pronounced increase in the concentration of triglycerides in the plasma high density lipoprotein (HDL) fraction. One case with this condition, an apparently healthy 61-year-old man, has been studied. Additional lipoprotein abnormalities were present, such as abnormally cholesterol-rich very low density lipoproteins (VLDL) with retarded electrophoretic mobility (beta-VLDL) and triglyceride enrichment of low density lipoproteins (LDL). The patient's plasma concentration of apolipoproteins A-I, A-II and B were normal and those of C-I, C-II, C-III and E were elevated. No abnormal forms of the soluble apolipoproteins of VLDL and high density lipoproteins (HDL) were found after analysis by isoelectric focusing. Lecithin:cholesterol acyltransferase activities, plasma cholesterol esterification rates and lipid transfer protein activities were normal. Post-heparin plasma activity of hepatic lipase was virtually absent and that of lipoprotein lipase was reduced by 50%. In plasma of this patient, HDL was almost exclusively present as large triglyceride-rich particles corresponding in size to particles of the HDL2 density fraction. The only brother of the patient also had hyper-alpha-triglyceridemia together with the other lipoprotein abnormalities described for the index case and deficiency of postheparin plasma activity of hepatic lipase. The findings presented below support the hypothesis that one primary function of hepatic lipase is associated with degradation of plasma HDL2. Deficiency of this enzyme activity thus causes accumulation of HDL2 in plasma leading to hyper-alpha-triglyceridemia. The results further suggest that the abnormal chemical and electrophoretic properties of VLDL and LDL in plasma from the patient, reminiscent of type III hyperlipoproteinemia, are secondary to the lack of the action of hepatic lipase on the HDL particles.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3739751     DOI: 10.1111/j.0954-6820.1986.tb03337.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  21 in total

Review 1.  Genetic basis of lipoprotein disorders.

Authors:  J L Breslow
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

2.  FoxO transcription factors are required for hepatic HDL cholesterol clearance.

Authors:  Samuel X Lee; Markus Heine; Christian Schlein; Rajasekhar Ramakrishnan; Jing Liu; Gabriella Belnavis; Ido Haimi; Alexander W Fischer; Henry N Ginsberg; Joerg Heeren; Franz Rinninger; Rebecca A Haeusler
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

3.  Severe hypercholesterolemia associated with decreased hepatic triglyceride lipase activity and pseudohyponatremia in patients after allogeneic stem cell transplantation.

Authors:  Yoshihiro Inamoto; Tamio Teramoto; Koji Shirai; Hideko Tsukamoto; Takaomi Sanda; Koichi Miyamura; Ikuo Yamamori; Noriyuki Hirabayashi; Yoshihisa Kodera
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

Review 4.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

5.  A new enzyme-linked immunosorbent assay system for human serum hepatic triglyceride lipase.

Authors:  Kazuya Miyashita; Katsuyuki Nakajima; Isamu Fukamachi; Yuji Muraba; Takafumi Koga; Yohnosuke Shimomura; Tetsuyo Machida; Masami Murakami; Junji Kobayashi
Journal:  J Lipid Res       Date:  2017-06-20       Impact factor: 5.922

6.  Long-term effect of pindolol on lipids and lipoproteins in men with newly diagnosed hypertension.

Authors:  A Terént; M Ribacke; L A Carlson
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.

Authors:  Mariko Tani; Katalin V Horvath; Benoit Lamarche; Patrick Couture; John R Burnett; Ernst J Schaefer; Bela F Asztalos
Journal:  Atherosclerosis       Date:  2016-08-20       Impact factor: 5.162

8.  A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma.

Authors:  S Imamura; J Kobayashi; K Nakajima; S Sakasegawa; A Nohara; T Noguchi; M A Kawashiri; A Inazu; S S Deeb; H Mabuchi; J D Brunzell
Journal:  J Lipid Res       Date:  2008-03-14       Impact factor: 5.922

9.  Association of an intronic haplotype of the LIPC gene with hyperalphalipoproteinemia in two independent populations.

Authors:  Hiroshi Iijima; Mitsuru Emi; Manabu Wada; Makoto Daimon; Sayumi Toriyama; Satoru Koyano; Hidenori Sato; Paul N Hopkins; Steven C Hunt; Isao Kubota; Sumio Kawata; Takeo Kato
Journal:  J Hum Genet       Date:  2007-12-27       Impact factor: 3.172

10.  Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.

Authors:  F Karpe; G Steiner; T Olivecrona; L A Carlson; A Hamsten
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.